AIMS: CD1a is a molecule belonging to the highly conserved group of CD1 proteins. Its expression in dendritic cells is related to the presentation of tumour-derived glycolipid antigens to T cells and, consequently, the development of a successful antitumour response. The aim was to investigate the presence of CD1a+ cells in both primary tumours and lymph nodes (LN) of a series of 35 invasive ductal carcinomas by both immunohistochemistry and reverse transcription-polymerase chain reaction. METHODS AND RESULTS: CD1a antigen was more expressed in N0 than N1 breast cancer (P < 0.0001) in both primary lesions and LN metastases and correlated positively and significantly with oestrogen (ER) (P = 0.0025) and progesterone (P = 0.0226) receptor (PR) status, as well as CD4+ and CD8+ T-lymphocyte infiltration. CONCLUSIONS: This is the first report to show a link between CD1a+ mononuclear cells in breast cancer and in paired LN metastases. The positive and significant correlations between the number of CD1a+ cells and positivity of the primary tumour for ER and PR suggest a possible role for CD1a as a prognostic marker for breast cancer, raising the possibility that hormone receptor-positive breast cancer patients may have a better prognosis in the presence of greater dendritic cell infiltration.
AIMS: CD1a is a molecule belonging to the highly conserved group of CD1 proteins. Its expression in dendritic cells is related to the presentation of tumour-derived glycolipid antigens to T cells and, consequently, the development of a successful antitumour response. The aim was to investigate the presence of CD1a+ cells in both primary tumours and lymph nodes (LN) of a series of 35 invasive ductal carcinomas by both immunohistochemistry and reverse transcription-polymerase chain reaction. METHODS AND RESULTS:CD1a antigen was more expressed in N0 than N1 breast cancer (P < 0.0001) in both primary lesions and LN metastases and correlated positively and significantly with oestrogen (ER) (P = 0.0025) and progesterone (P = 0.0226) receptor (PR) status, as well as CD4+ and CD8+ T-lymphocyte infiltration. CONCLUSIONS: This is the first report to show a link between CD1a+ mononuclear cells in breast cancer and in paired LN metastases. The positive and significant correlations between the number of CD1a+ cells and positivity of the primary tumour for ER and PR suggest a possible role for CD1a as a prognostic marker for breast cancer, raising the possibility that hormone receptor-positive breast cancerpatients may have a better prognosis in the presence of greater dendritic cell infiltration.
Authors: Tiziana Corsello; Giandomenico Amico; Simona Corrao; Rita Anzalone; Francesca Timoneri; Melania Lo Iacono; Eleonora Russo; Giovanni Francesco Spatola; Maria Laura Uzzo; Mario Giuffrè; Martin Caprnda; Peter Kubatka; Peter Kruzliak; Pier Giulio Conaldi; Giampiero La Rocca Journal: Stem Cell Rev Rep Date: 2019-12 Impact factor: 5.739
Authors: Hossein Golmoghaddam; Abdul Mohammad Pezeshki; Abbas Ghaderi; Mehrnoosh Doroudchi Journal: Pathol Oncol Res Date: 2011-01-22 Impact factor: 3.201
Authors: Francisco Esteban; Francisco Ruiz-Cabello; Miguel Angel Gonzalez-Moles; Miguel Angel Lopez-Gonzalez; Rafael Funez; Maximino Redondo Journal: J Oncol Date: 2012-02-09 Impact factor: 4.375
Authors: Ankita Singh Rathore; Sandeep Kumar; Rituraj Konwar; Annu Makker; M P S Negi; Madhu Mati Goel Journal: Indian J Med Res Date: 2014-09 Impact factor: 2.375
Authors: Grzegorz Dyduch; Katarzyna Ewa Tyrak; Anna Glajcar; Joanna Szpor; Magdalena Ulatowska-Białas; Krzysztof Okoń Journal: Biomed Res Int Date: 2017-02-26 Impact factor: 3.411